In: Finance
Below is the income statement of a publicly-traded biotech company from 2004 until 2007:
Year |
2004 |
2005 |
2006 |
2007 |
Revenue |
$0 |
$0 |
$0 |
$0 |
Expenses |
$0.2 million |
$0.7 million |
$2.2 million |
$4.8 million |
The company’s stock was trading for $2 in 2004 and is now trading for $7. Are investors irrational? Should the stock be sold short? Is it possible for a company in the biotech business to be worth something even though it has no current sales? What can justify the billion-dollar values of technology companies which have yet to earn any profits?